EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Evidence-Based Recommendations on Pharmacologic Treatment for Migraine Prevention: A Clinical Practice Guideline from the Korean Headache Society

Byung-Su Kim, Pil-Wook Chung, Jae Myun Chung, Kwang-Yeol Park, Heui-Soo Moon, Hong-Kyun Park, Dae-Woong Bae, Jong-Geun Seo, Jong-Hee Sohn, Tae-Jin Song, Seung-Han Lee, Kyungmi Oh und 4 weitere

Headache and Pain Research · 28.02.2025 · 26 (1) · 5-20

DOI: 10.62087/hpr.2024.0019 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Headache and Pain Research, erschienen am 28.02.2025. Verfasst von Byung-Su Kim und 15 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The aim of this clinical practice guideline (CPG) from the Korean Headache Society is to provide evidence-based recommendations on the pharmacologic treatment for migraine prevention in adult migraine patients.

Methods

The present CPG was developed based on the guideline adaptation methodology through a comprehensive systematic search for literature published between January 2012 and July 2020. The overall quality of the CPGs was assessed using the Korean version of the Appraisal of Guidelines for Research and Evaluation II tool. High-quality CPGs were adapted to make key recommendations in terms of strength (strong or weak) and direction (for or against).

Results

The authors selected nine available high-quality guidelines throughout the process of assessment of quality. Regarding oral migraine preventive medications, propranolol, metoprolol, flunarizine, sodium divalproex, and valproic acid are recommended to adult patients with episodic migraines based on high-quality evidence (“strong for”). Topiramate can be recommended for either episodic or chronic migraine (“strong for”). For migraine prevention using calcitonin gene-related peptide monoclonal antibodies, galcanezumab, fremanezumab, erenumab, and eptinezumab are recommended for adult patients with either episodic or chronic migraine on the basis of high-quality evidence (“strong for”). OnabotulinumtoxinA is recommended for adult patients with chronic migraine based on high-quality evidence (“strong for”). Last, frovatriptan, naratriptan, and zolmitriptan are recommended for short-term prevention in women with menstrual migraine (“strong for”).

Conclusion

In the present CPG, the authors provide specific, straightforward, and easy-to-implement evidence-based recommendations for pharmacologic migraine prevention. Nevertheless, these recommendations should be applied in real-world clinical practice based on optimal individualization.

Zitieren

APA

Kim, B., Chung, P., Chung, J. M., Park, K., Moon, H., Park, H., Bae, D., Seo, J., Sohn, J., Song, T., Lee, S., Oh, K., Lee, M. J., Cha, M., Choi, Y., & Choi, M. (2025). Evidence-Based Recommendations on Pharmacologic Treatment for Migraine Prevention: A Clinical Practice Guideline from the Korean Headache Society. Headache and Pain Research, 26(1), 5-20. https://doi.org/10.62087/hpr.2024.0019

Vancouver

Kim B, Chung P, Chung JM, Park K, Moon H, Park H, et al. Evidence-Based Recommendations on Pharmacologic Treatment for Migraine Prevention: A Clinical Practice Guideline from the Korean Headache Society. Headache and Pain Research. 2025;26(1):5-20. doi:10.62087/hpr.2024.0019

BibTeX
@article{Kim2025,
  author = {Kim, Byung-Su and Chung, Pil-Wook and Chung, Jae Myun and Park, Kwang-Yeol and Moon, Heui-Soo and Park, Hong-Kyun and Bae, Dae-Woong and Seo, Jong-Geun and Sohn, Jong-Hee and Song, Tae-Jin and Lee, Seung-Han and Oh, Kyungmi and Lee, Mi Ji and Cha, Myoung-Jin and Choi, Yun-Ju and Choi, Miyoung},
  title = {Evidence-Based Recommendations on Pharmacologic Treatment for Migraine Prevention: A Clinical Practice Guideline from the Korean Headache Society},
  journal = {Headache and Pain Research},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {5--20},
  doi = {10.62087/hpr.2024.0019}
}
Kostenlos starten →